Good evening :)
$
₹
enVVeno Medical Corp

enVVeno Medical Corp

NVNO

NASDAQ
Asset Logo

enVVeno Medical Corp

NVNO

NASDAQ
$9.242.15% (+0.19)
$
₹
$9.242.15% (+0.19)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Devices

Micro Cap

With a market cap of $6.2M the stock is ranked 5891

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.30
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-24.97
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 1 analyst's reports

Buy
1 analyst
Hold
0 analyst
Sell
0 analyst

Analysts expect a +231.49% price upside over the next year

Current Price$9.24
Target Price$30

Company Profile

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Peers

Peers

Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
33.20
33.20
1Y Return
24.55%
24.55%
Buy Reco %
74.07
74.07
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
37.75
37.75
1Y Return
13.52%
13.52%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
45.05
45.05
1Y Return
9.65%
9.65%
Buy Reco %
66.66
66.66
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
22.69
22.69
1Y Return
2.29%
2.29%
Buy Reco %
53.12
53.12
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
28.48
28.48
1Y Return
27.34%
27.34%
Buy Reco %
68.75
68.75

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Devices

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
enVVeno Medical Corp -0.30-
Abbott Laboratories33.203.471.88
Danaher Corporation37.752.831.26

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

-4.5
-3.7
-3.8
-3.6
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue0000.81000000
Net Income-4.99-4.95-5.64-6.22-4.50-6.69-4.53-3.73-3.84-3.6
Net Profit Margin----767.11%------
See CostsAll values in $ Million

Frequently asked questions

  1. enVVeno Medical Corp (NVNO) share price today is $9.24 as of September 22, 2026 at 8:01 PM IST. The stock touched a day high of $9.36 and a day low of $8.51.

  2. enVVeno Medical Corp stock trades on NASDAQ under the ticker symbol NVNO.

  3. enVVeno Medical Corp's market capitalization is $6.23M as of September 22, 2026 at 8:01 PM IST.

  4. enVVeno Medical Corp's price-to-earnings (P/E) ratio is N/A as of September 22, 2026.

  5. enVVeno Medical Corp's price-to-book (P/B) ratio is 0.30 as of September 22, 2026.

  6. Yes, You can buy enVVeno Medical Corp shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy enVVeno Medical Corp shares in three steps: 1. Search enVVeno Medical Corp on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since enVVeno Medical Corp trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in enVVeno Medical Corp (NVNO) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 1.0816 shares at the current price of $9.24.

Loading...